Neurology & Immunology

We have a long heritage in researching, supporting and advocating for people with neurological and immunological diseases, in and out of the laboratory.


Our Products

We are committed to understanding the journey people living with MS face and delivering meaningful solutions that help address therapeutic needs of individual patients.

MAVENCLAD® (cladribine) tablets 10mg

Rebif® (interferon beta-1a) subcutaneous injection

leaders in Multiple Sclerosis

EMD Serono's experience and scientific discoveries in MS date back more than 20 years. We have an ongoing commitment to improving the entire patient experience. To this end, we offer delivery devices for our therapeutic products as well as comprehensive patient education resources.

It is the people living with MS or those who will be diagnosed with MS, their caregivers and healthcare providers who have been our catalyst and inspiration to continue innovating, collaborating and advocating.

Beyond Medications

Comprehensive Care Resources

We know that caring for someone with MS goes beyond providing medicines, which is why we work to support people with educational programs and financial resources to address concerns about treatment and access.

For more than 17 years, MS LifeLines® has provided valuable education, information about our treatment and financial assistance programs for eligible people to address concerns about their treatment and access.

Learn more on MSLifeLines.com

Curiosity Drives Our Future

With our history in neurology and leadership as a science-driven organization, we are deepening our commitment to people with neurological and immunological diseases by researching new therapeutic options that can make a real difference in their lives.

The development and discovery of innovative treatments for MS remains a top focus for our scientists. Our pipeline has potential to impact treatment across multiple immunological conditions, including MS, rheumatoid arthritis and systemic lupus erythematosus.

We are also investigating new treatments for immunological conditions such as psoriasis.

Our Pipeline

Browse the programs in our pipeline to see what we're currently working on by phase, therapeutic area and compound type.

View Our Pipeline

Redirect

You have accessed https://www.emdserono.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Site Exit Disclaimer

You are now leaving the website of EMD Serono, the biopharma business of Merck KGaA, Darmstadt, Germany. This link will either lead to a different website maintained by EMD Serono/its global business, or a different website/resource maintained by 3rd parties.

If you are visiting a 3rd party website, we have no control over the content and are not responsible for and make no representation as to the accuracy or any other aspect of such resource or the privacy practices of such 3rd party. Providing links to a 3rd party website does not constitute EMD Serono’s endorsement of such website or the information or products presented on such website. 

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement